Benicar MDL Cases Survive Daiichi's Symptom Challenges
A New Jersey federal judge on Monday declined drugmaker Daiichi Sankyo Inc.'s efforts to boot cases from centralized litigation over the blood pressure drug Benicar with allegedly tenuous connections between consumers' gastrointestinal problems...To view the full article, register now.
Already a subscriber? Click here to view full article